Hadas Nicole R. - Insider Non-Derivative Transactions at Akebia Therapeutics, Inc. (AKBA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 13, 2024, Hadas Nicole R.'s relationship to Akebia Therapeutics, Inc. (AKBA) is Officer (SVP, Chief Legal Officer), and currently has 651,243 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKBA insiders.

Data Source: SEC.
Hadas Nicole R. - Insider Non-Derivative Transactions of AKBA Common Stock
Hadas Nicole R. - Insider Non-Derivative Transactions at AKBA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
May 14, 2024 Sell -- (Common Stock) 12016 1.26 651243
Mar 1, 2024 Sell -- (Common Stock) 5974 1.58 663259
Feb 28, 2024 Sell -- (Common Stock) 7411 1.52 669233
Feb 1, 2024 Acquisition -- (Common Stock) 149300 0 676644
May 26, 2023 Sell -- (Common Stock) 63186 1.22 524344
May 25, 2023 Acquisition -- (Common Stock) 200000 0 587530
May 13, 2023 Acquisition -- (Common Stock) 100000 0 387530
Mar 2, 2023 Sell -- (Common Stock) 1088 0.88 287530
Mar 2, 2023 Sell -- (Common Stock) 6613 0.88 288618
Mar 2, 2023 Sell -- (Common Stock) 5333 0.88 295231
Feb 28, 2023 Sell -- (Common Stock) 6677 0.81 300564